Nicotinic Signaling Stimulates Glucagon Secretion in Mouse and Human Pancreatic α-Cells
Diabetes · 01.01.2025 · 74 (1) · 53-64
DOI: 10.2337/db23-0809 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, online erschienen am 30.10.2024. Verfasst von Alexander Hamilton und 9 weiteren Autor:innen. Beteiligte Einrichtung: Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford and Churchill Hospital, Oxford, U.K. Hauptthemen laut MEDLINE: Glucagon-Secreting Cells, Glucagon, Nicotine, Signal Transduction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Oxford Biomedical Research Council, Diabetes UK.
Abstract (Originalsprache)
Smoking is widely regarded as a risk factor for type 2 diabetes because nicotine contributes to insulin resistance by desensitizing the insulin receptors in muscle, liver, or fat. Little is known, however, about the immediate regulation of islet hormonal output by nicotine, an agonist of ionotropic cholinergic receptors. We investigated this by imaging cytosolic Ca2+ dynamics in mouse and human islets using confocal microscopy and measuring glucagon secretion in response to the alkaloid from isolated mouse islets. Nicotine acutely stimulated cytosolic Ca2+ in glucagon-secreting α-cells but not in insulin-secreting β-cells. The 2.8- ± 0.5-fold (P < 0.05) increase in Ca2+, observed in >70% of α-cells, correlated well with a 2.5- ± 0.3-fold stimulation of glucagon secretion. Nicotine-induced elevation of cytosolic Ca2+ relied on influx from the extracellular compartment rather than release of the cation from intracellular depots. Metabotropic cholinergic signaling, monitored at the level of intracellular diacylglycerol, was limited to 69% of α-cells versus 94% of β-cells. We conclude that parasympathetic regulation of pancreatic islet hormone release uses different signaling pathways in β-cells (metabotropic) and α-cells (metabotropic and ionotropic), resulting in the fine-tuning of acetylcholine-induced glucagon exocytosis. Sustained nicotinic stimulation is, therefore, likely to attenuate insulin sensitivity by increasing glucagon release. Article Highlights
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford and Churchill Hospital, Oxford, U.K.
- Unit of Molecular Metabolism, Clinical Research Centre, Lund University Diabetes Centre, Lund University and Malmö University Hospital, Malmö, Sweden.
- Department of Biology, University of Copenhagen, Copenhagen, Denmark.
- Center for Neuroscience and Cell Biology, Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.
- Department of Endocrinology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- Metabolic Research Unit, Department of Physiology, Institute of Neuroscience and Physiology, University of Göteborg, Göteborg, Sweden.
ORCID-Profile: Jakob G Knudsen, Andrei I Tarasov
Förderung
- Oxford Biomedical Research Council
- Diabetes UK
Zitieren
APA
Hamilton, A., Zhang, Q., Gao, R., Hill, T. G., Salehi, A., Knudsen, J. G., Draper, M. B., Johnson, P. R. V., Rorsman, P., & Tarasov, A. I. (2025). Nicotinic Signaling Stimulates Glucagon Secretion in Mouse and Human Pancreatic α-Cells. Diabetes, 74(1), 53-64. https://doi.org/10.2337/db23-0809
Vancouver
Hamilton A, Zhang Q, Gao R, Hill TG, Salehi A, Knudsen JG, et al. Nicotinic Signaling Stimulates Glucagon Secretion in Mouse and Human Pancreatic α-Cells. Diabetes. 2025;74(1):53-64. doi:10.2337/db23-0809
BibTeX
@article{Hamilton2025,
author = {Hamilton, Alexander and Zhang, Quan and Gao, Rui and Hill, Thomas G and Salehi, Albert and Knudsen, Jakob G and Draper, Matthew B and Johnson, Paul R V and Rorsman, Patrik and Tarasov, Andrei I},
title = {Nicotinic Signaling Stimulates Glucagon Secretion in Mouse and Human Pancreatic α-Cells},
journal = {Diabetes},
year = {2025},
volume = {74},
number = {1},
pages = {53--64},
doi = {10.2337/db23-0809}
}
EUVIMED